Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2382-2015Class II

Celsite Implantable Access Port System, model ST301. The Celsite Implantable Access Port Systems (Celsite...

B. BRAUN INTERVENTIONAL SYSTEMS Inc. / initiated 2015-06-16 / Terminated / root cause: sterility

B. Braun Interventional Systems began a recall of Celsite Implantable Access Port System, model ST301. The Celsite Implantable Access Port Systems (Celsite port systems) are implantable port and catheter... on . FDA classified it as Class II and gives the reason as "The manufacturer, B. Braun medical France, received endotoxin test results that are out of specification for the peelable sheath (A1537)". As of , the recall status on record is Terminated, and MDM tags the root cause as sterility.

Recall record

Recall number
Z-2382-2015
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
B. BRAUN INTERVENTIONAL SYSTEMS Inc.
Product
Celsite Implantable Access Port System, model ST301. The Celsite Implantable Access Port Systems (Celsite port systems) are implantable port and catheter systems that allow safe, repeated access to the patient's bloodstream. The port chamber and catheter design can be used for the administration of medication and fluids. The Celsite system consists of an access port with a silicone septum, which is connected to a catheter using a connection ring. The triangular shaped access port has a low profile nose, finger stops on the side of the housing, and a round base. Celsite access ports have suture holes or suture zones to secure placement during implantation.
Product code
LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Reason for recall
The manufacturer, B. Braun medical France, received endotoxin test results that are out of specification for the peelable sheath (A1537).
Root cause tag
sterility
FDA root cause
Unknown/Undetermined by firm
Action
An Urgent Medical Device Recall letter, dated 6/16/2015 was sent to the 2 consignees via express mail. The letter explained the issue and requested the hospital review their inventory for the affected model and lot. If any quantities of the lot remained in inventory, the product was to be returned to BIS. A BIS sales representative will personally visit each account and complete an inventory sheet. Customers with questions can contact Paul O-Connell, President at 1-847-274-0097
Quantity in commerce
11 units
Distribution
CA and NY only.
Product codes and lots
Lot number: 36896615

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2382-2015
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2382-2015Class IITerminatedVoluntary: Firm initiated